SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-125941
Filing Date
2024-11-13
Accepted
2024-11-13 07:32:13
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 lxeo_424b3_20241113_8-k.htm 424B3 53285
2 EX-99.1 lxeo-ex99_1.htm EX-99.1 141733
3 GRAPHIC img46940271_0.jpg GRAPHIC 194234
4 GRAPHIC img103703674_0.jpg GRAPHIC 5674
  Complete submission text file 0000950170-24-125941.txt   450930
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278566 | Film No.: 241451192
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)